By
Drug Target Review2024-03-12T16:00:20
Results from an in vivo CRISPR knockout screen, targeting genes involved in autophagy, could lead to new therapies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-20T13:00:00Z
2026-11-20T08:00:00Z
Contributor Dr Rahul Gupta, By Drug Target Review
2026-07-21T09:36:00
Contributor Jayson Uffens, By Drug Target Review
2026-05-25T07:00:00
Contributor Professor Neville Sanjana
2026-11-18T07:00:00
Contributor Dr Bryan McClellan and Dr William Matsui, By Drug Target Review
2026-09-03T07:00:00
Contributor Marty Parrish and Steve Hoffmann, By Drug Target Review
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
2026-08-03T06:00:00
Author Dr Xiaoxiao Wang, Yan Zhang and Junli Zhao
Site powered by Webvision Cloud